A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

The commercialisation of junk food, increase in inactive lifestyles with prolonged sitting, and high stress environments, ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

A new report noted that body mass index does not provide a nuanced enough assessment of health as it relates to weight ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...